Interplay between nanomedicine and protein corona-Reference-Cited by-同舟云学术

Interplay between nanomedicine and protein corona

Published:2021 Issue:34 Volume:9 Page:6713-6727
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Yang Min¹,Wu Ercan²,Tang Wenjing²,Qian Jun²,Zhan Changyou¹²^ORCID

Affiliation:

1. Department of Pharmacology, School of Basic Medical Sciences & Center of Medical Research and Innovation, Shanghai Pudong Hospital & State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200032, P. R. China

2. MOE Key Laboratory of Smart Drug Delivery, School of Pharmacy, Fudan University, Shanghai 201203, P. R. China

Abstract

Protein corona (PC) severely affects the in vivo performance of nanomedicines. Regulation of interplay between nanomedicines and PC may provide a new avenue for precise medication.

Funder

National Natural Science Foundation of China

Shanghai Municipal Education Commission

Natural Science Foundation of Shanghai

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2021/TB/D1TB01063H

Reference186 articles.

1. Nanomedicine